Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial.
Lancet HIV
; 3(4): e158-65, 2016 Apr.
Article
in En
| MEDLINE
| ID: mdl-27036991
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenine
/
HIV Infections
/
HIV-1
/
Anti-HIV Agents
/
Tenofovir
/
Emtricitabine
Type of study:
Clinical_trials
/
Guideline
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet HIV
Year:
2016
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands